Depression commonplace in people with heart disease
The American Heart Association has issued new guidelines recommending that all patients with heart disease should be routinely screened for depression.
Numerous studies have shown that depression is more prevalent in people with coronary heart disease than it is in the general population. For example, depression is three times more common among people who have recently had a heart attack – 15-20% of heart attack patients meet diagnostic criteria for major depression, and even more patients have an elevated level of depressive symptoms. Furthermore, research has shown that depression increases the risk of further/recurrent cardiovascular morbidity, whilst also increasing the risk of cardiovascular mortality.
These findings have led to the issue of the new guidelines:
- All patients with coronary heart disease should be screened for depression.
- Patients with positive screening results should be evaluated by a professional qualified in the diagnosis and management of depression.
- Treatment should be tailored to the individual patient. Treatment options include: antidepressant drugs, cognitive behavioral therapy, and physical activity/exercise.
- Sertraline and citalopram are the first-line antidepressant drugs for patients with coronary heart disease.
- Patients with cardiac disease who are under treatment for depression should be carefully monitored for adherence to their medical care, drug efficacy, and safety, with respect to both their cardiovascular and mental health
Lichtman JH, Bigger JT, Blumenthal JA, Frasure-Smith N, Kaufman PG,Lespérance F, Mark DB, Sheps DS, Taylor CD, Froelicher ES.Depression and Coronary Heart Disease. Recommendations for Screening, Referral, and Treatment. A Science Advisory From the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research. Circulation. Published online before print September 29, 2008, doi: 10.1161/CIRCULATIONAHA.108.190769.
Health Headlines
upcoming Events
U.S. Events
congresses
fellowships
-
Aesthetic Medicine Module I
Las Vegas, NV | Dec. 9-10, 2009 -
Anti-Aging & Regenerative Medicine Modules I, II, III & IX
Las Vegas, NV | Dec. 10-12, 2009 -
Preventative Medicine, Nutrition & Sports Medicine Module I
Las Vegas, NV | Dec. 9-11, 2009 -
Fellowship in Preventative Medicine, Nutrition & Sports Medicine Module III
Las Vegas, NV | Dec. 11-12, 2009
symposium
-
Advanced Hormone Symposium
Chicago, IL | Oct. 8-10, 2010
VIDEO: Brain Age Workshop
Dr. Eric Braverman, Director of The Place for Achieving Total Health
(PATH Medical), Chairs the
Brain Age Workshop taking place Dec. 9, 2009.
Held in conjunction with the Winter Session of the 17th Annual World
Congress on Anti-Aging Medicine & Regenerative Biomedical Technologies.
The Brain Age Workshop features presentations on Brain Mind Assessment
via Neuropsychological Analysis, Movement Deficiency Syndrome,
Hormones and the Brain, Nootropic Drug Mechanisms, and Traumatic Brain
Injury. View this video to learn about Dr. Braverman’s brain-based
model of aging and age modulation.
International Events
- Mexico City | Jan. 15-17, 2010
- Milan | Mar. 18-20, 2010
- Kuala Lumpur | Apr. 29 - May 2, 2010
- Jakarta | May 2010 (pending)
- Bucharest | May 2010 (pending)
- Seoul | May 2010 (pending)
- Melbourne | Aug. 21-22, 2010
- Dubai | Oct. 26-27, 2010
- Bali | October 2010 (pending)
- Mainz-Frankfurt | Nov. 8-10, 2010
- Sao Paulo | Nov. 12-14, 2010
- Shanghai | November 2010 (pending)





